HCV Tissue Culture System Using Recombinant Genomic Constructs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing infectious hepatitis C virus (HCV) particles in cell culture are inefficient and inadequate for testing antiviral therapeutics, as HCV grows poorly in cell culture and existing replication systems fail to produce infectious viral particles or emulate all steps of the HCV life cycle.
Innovation Solution
A reliable cell culture system is developed using recombinant monocistronic and bicistronic genomic constructs in hepatocytes or liver-derived cells, incorporating an RNA silencing suppressor and CD81 to enhance viral replication and infectivity, along with a neutralization assay to measure protective immunity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If HCV is cultured in conventional cell culture systems, then viral replication can be observed, but the system fails to produce infectious viral particles efficiently
Solution Approach 1:
The HCV genome is divided into multiple cistrons (structural and nonstructural proteins) that are expressed separately in the cell culture system. This segmentation allows for controlled expression of individual viral components, enabling the production of infectious particles while maintaining reliable replication through systematic assembly of viral elements.
Solution Approach 2:
The cell culture system is pre-configured with necessary cellular factors, receptors (such as CD81), and co-factors before HCV introduction. This preliminary preparation ensures that when the virus is introduced, all necessary components for infectious particle production are already in place, resolving the contradiction between reliability of production and productivity of replication.
2Adaptability or versatility
If existing replication systems are used to test antiviral strategies, then some antiviral effects can be observed, but the systems are inadequate for testing all antiviral mechanisms
Solution Approach 1:
The cell culture system is designed with universal applicability to test multiple antiviral strategies simultaneously. By incorporating complete HCV life cycle components (entry, replication, assembly, release) in a single system, it can reliably emulate all viral processes while maintaining versatility for testing various antiviral mechanisms, resolving the contradiction between adaptability and reliability.
3Productivity
If subgenomic replicons are used to improve replication efficiency, then viral RNA replication increases, but infectious viral particles are not produced
Solution Approach 1:
The system merges subgenomic replicon technology (for high RNA replication) with full-genome constructs (for infectious particle production). By combining these approaches, the system achieves both high productivity in RNA replication and reliability in infectious particle generation, as the replicon ensures efficient replication while the complete genome enables proper assembly and release of infectious virions.
Data Source
AI summary
A tissue culture system for production of infectious hepatitis C virus is described. In particular, the invention provides recombinant monocistronic and bicistronic genomic constructs for production of virus, including constructs for production of wild-type HCV type 2a strain JFH1 and constructs for production of chimeric viruses comprising HCV proteins from strain JFH1 and a second HCV isolate. Constructs of the invention also include a reporter gene to facilitate measurement of RNA replication and viral infectivity in cultures. The cell culture system may also include various factors that improve viral replication or infectivity. In addition, a neutralization assay using HCV grown in cell culture is described.